Cordex and Avanzanite Announce Licensing Agreement for Zemcelpro Cell Therapy in Europe
ExCellThera Inc. subsidiary Cordex Biologics announced exclusive licensing and supply agreements granting Avanzanite Bioscience B.V. commercialization rights for Zemcelpro across 32 European countries on November 9, 2026. The deal covers … Read More